Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyKaren Sliwa, John J.V. McMurray, Denise Hilfiker‐Kleiner et al.|European Journal of Heart Failure|2010Cited by 1.1k
α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomereLudwig Thierfelder, Christine E. Seidman, Hugh Watkins et al.|Cell|1994Cited by 1k
Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic CardiomyopathyHugh Watkins, Christine E. Seidman, William J. McKenna et al.|New England Journal of Medicine|1995Cited by 932
Genomic Risk Prediction of Coronary Artery Disease in 480,000 AdultsMichael Inouye, Nilesh J. Samani, Gad Abraham et al.|Journal of the American College of Cardiology|2018Cited by 832
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic CardiomyopathyHideshi Niimura, Halldóra Björnsdóttir, Linda L. Bachinski et al.|New England Journal of Medicine|1998Cited by 759